The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Evaluation of the response assessment criteria in newly diagnosed and recurrent glioblastoma.
 
Gilbert Youssef
No Relationships to Disclose
 
Rifaquat Rahman
Research Funding - Bristol-Myers Squibb (Inst)
 
Mary Jane Lim-Fat
No Relationships to Disclose
 
Camden Bay
Employment - Sarepta Therapeutics (I); Vertex (I)
Stock and Other Ownership Interests - Sarepta Therapeutics (I); Vertex (I)
 
Wenya Linda L. Bi
No Relationships to Disclose
 
Daniel Cagney
No Relationships to Disclose
 
YuhShin Chang
Research Funding - massachusetts general hospital
 
Matthew Nicholas Desalvo
No Relationships to Disclose
 
Thomas Flood
No Relationships to Disclose
 
Elizabeth R. Gerstner
Consulting or Advisory Role - Array BioPharma (I); MyoKardia (I)
 
Luis Nicolas Gonzalez Castro
Stock and Other Ownership Interests - Takeda (I)
Honoraria - Oakstone Publishing
Consulting or Advisory Role - Elsevier; Teladoc
Research Funding - American Society of Clinical Oncology; NIH/NCI
 
Jeffrey Guenette
No Relationships to Disclose
 
Albert Eusik Kim
No Relationships to Disclose
 
Eudocia Quant Lee
Honoraria - Continuum (American Academy of Neurology); Medlink
Consulting or Advisory Role - Medscape
Patents, Royalties, Other Intellectual Property - Royalties from Wolter Kluwer for Up to Date, Inc
 
J. Ricardo Ricardo McFaline Figueroa
(OPTIONAL) Uncompensated Relationships - Crimson BioPharm
 
Christopher Potter
No Relationships to Disclose
 
David A. Reardon
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novocure; Oncorus; Regeneron; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Bayer; Bristol-Myers Squibb; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Imvax; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; Novocure; Oncorus; Regeneron; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Omniox
 
Benjamin M. Ellingson
Consulting or Advisory Role - Alpheus Medical; Chimerix; Ellipses Pharma; Global Coalition for Adaptive Research; Imaging Endpoints; ImmunoGenesis; Janssen; Kazia Therapeutics; Medicenna; MedQIA; Monteris Medical; Neosoma; SERVIER; Siemens; Sumitomo Dainippon Pharma Oncology; VBL Therapeutics
Research Funding - Janssen; Siemens
Travel, Accommodations, Expenses - Siemens
 
Raymond Yi-kun Huang
Consulting or Advisory Role - Nuvation Bio; Vysioneer
Research Funding - Agios
 
Patrick Y. Wen
Consulting or Advisory Role - Agios; AstraZeneca; Bayer; Black Diamond Therapeutics; Blue Earth Diagnostics; Boston Pharmaceuticals; Celularity; Chimerix; Day One Biopharmaceuticals; ElevateBio; Imvax; Integral Health; Karyopharm Therapeutics; Merck; Mundipharma; Novartis; Novocure; Nuvation Bio; Prelude Therapeutics; QED Therapeutics; Sapience Therapeutics; Tocagen; Vascular Biogenics; VBI Vaccines; Voyager Therapeutics
Research Funding - Agios (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Bayer (Inst); Beigene (Inst); Celgene (Inst); Chimerix (Inst); Karyopharm Therapeutics (Inst); Kazia Therapeutics (Inst); Lilly (Inst); MediciNova (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Oncoceutics (Inst); Puma Biotechnology (Inst); Vascular Biogenics (Inst); VBI Vaccines (Inst)